Skip to content
★ Sign in to follow
EM
Total declarations
7
Company
1
▲ Purchases (2 ops.)
€17k
▼ Sales (0 ops.)
—

Latest filing published 14 Jan 2025 for CorMedix Inc., €62k.

Filing timeline

BuySale
Erin Mistry

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Erin Mistry: trading record in brief

All filings by Erin Mistry on record concern CorMedix Inc. The record holds 7 filings, for trades running from 17 November 2023 to 10 January 2025.

Purchases make up the whole of the open-market record (2 purchases, €17k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants.

The record was last updated on 14 January 2025 with a share grant (€62k) in CorMedix Inc. The last purchase on record was published on 13 December 2024, which is 695 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Erin Mistry

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    EVP, Chief Commercial OfficerExecutivesCorMedix Inc.
    63,660 USD21SEC
    5,689 shares@ US$11.1978.0% of flowCommon StockSEC:0001213900-25-003533:0
  • ◆
    EVP, Chief Commercial OfficerExecutivesCorMedix Inc.
    0SEC
    62,500 shares0Common StockSEC:0001213900-25-001358:0
  • ▲
    EVP, Chief Commercial OfficerExecutivesCorMedix Inc.
    14,985 USD15SEC
    1,500 shares@ US$9.989917.4% of flowCommon StockSEC:0000899140-24-001352:0
    Canonical exit: 29 Jan 2025 (T+90)
  • ◆
    Chief Commercial OfficerExecutivesCorMedix Inc.
    0SEC
    50,000 shares0Common StockSEC:0000929638-24-000132:0
  • ▲
    Chief Commercial OfficerExecutivesCorMedix Inc.
    4,000 USD11SEC
    1,000 shares@ US$4.004.6% of flowCommon StockSEC:0000929638-23-003205:0
    Canonical exit: 15 Feb 2024 (T+90)

5 of 5 declarations